Maryland State Retirement & Pension System’s Coherus Oncology CHRS Stock Holding History

Maryland State Retirement & Pension System’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,321	Closed	-$180K	–	1567
2023 Q1	$180K	Hold	26,321	–	–	﹤0.01%	1487
2022 Q4	$208K	Hold	26,321	–	–	0.01%	1434
2022 Q3	$253K	Buy	26,321 +542	+2%	+$5.49K	0.02%	467
2022 Q2	$187K	Hold	25,779	–	–	0.01%	1446
2022 Q1	$333K	Buy	25,779 +372	+1%	+$4.73K	0.01%	1296
2021 Q4	$405K	Buy	25,407 +430	+2%	+$7.52K	0.01%	1215
2021 Q3	$409K	Buy	+24,977	New	+$366K	0.01%	1201

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Maryland State Retirement & Pension System's CHRS Position: Q2 2023 in Review

Maryland State Retirement & Pension System sold out of Coherus Oncology (CHRS) in Q2 2023, closing a stake of 26,321 shares — an estimated $180K sold.

Maryland State Retirement & Pension System first reported a position in CHRS in Q3 2021 and held it in 7 quarters. The position peaked at $409K in Q3 2021. 161 funds tracked by Wall St. Rank hold CHRS as of Q2 2023.

Maryland State Retirement & Pension System reported no remaining Coherus Oncology position as of Q2 2023 after selling out during the quarter.
Maryland State Retirement & Pension System sold 26,321 Coherus Oncology shares in Q2 2023, an estimated $180K.
Maryland State Retirement & Pension System first reported a position in Coherus Oncology in Q3 2021 and held it in 7 quarters.
Maryland State Retirement & Pension System's Coherus Oncology position peaked at $409K in Q3 2021.
161 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2023, filed 11 Jul 2023.